Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements Of Operations

v3.8.0.1
Condensed Consolidated Statements Of Operations - USD ($)
3 Months Ended 6 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Mar. 31, 2018
Mar. 31, 2017
Condensed Consolidated Statements Of Operations [Abstract]        
Net revenues $ 2,572,872 $ 2,405,519 $ 5,159,485 $ 5,649,118
Cost of sales 1,373,469 1,127,864 2,645,570 2,719,179
Gross profit 1,199,403 1,277,655 2,513,915 2,929,939
Operating expenses:        
Research and development 2,076,794 1,207,561 4,035,162 1,374,959
Selling, general and administrative 3,819,159 2,541,312 6,847,748 5,074,518
Loss on settlement of accounts receivable     3,764,137  
Business acquisition   108,015   934,385
Total operating expenses 5,895,953 3,856,888 14,647,047 7,383,862
Operating loss (4,696,550) (2,579,233) (12,133,132) (4,453,923)
Non-operating expenses:        
Interest expense (350,595) (350,595)
Other expense, net (2,411) (12,686) (15,580) (22,307)
Change in fair value of derivative liabilities (21,000) (21,000)
Foreign currency transaction loss (63,077) (8,756) (116,532) (20,695)
Total non-operating expense (437,083) (21,442) (503,707) (43,002)
Loss before income taxes (5,133,633) (2,600,675) (12,636,839) (4,496,925)
Income tax benefit (1,302,416) (824,033) (4,548,469) (1,354,102)
Net loss $ (3,831,217) $ (1,776,642) $ (8,088,370) $ (3,142,823)
Net (loss) per basic and diluted common share outstanding $ (0.07) $ (0.06) $ (0.15) $ (0.10)
Basic and diluted weighted average common shares outstanding 53,355,944 30,982,497 53,253,901 30,979,283